EPIRUS Biopharmaceuticals, Inc. 4
4 · EPIRUS Biopharmaceuticals, Inc. · Filed Nov 3, 2015
Insider Transaction Report
Form 4
Shea Thomas A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-11-02+56,842→ 56,842 totalExercise: $5.55Exp: 2025-11-02→ Common Stock (56,842 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest on the one year anniversary of the grant date and the remaining shares shall vest in substantially equal monthly installments over the next three (3) years, provided the Reporting Person remains continuously employed by the Issuer through each vesting date.